Rosty Raykov is of FENNEC PHARMACEUTICALS INC.. Currently has a direct ownership of 83,863 shares of FENC, which is worth approximately $545,109. The most recent transaction as insider was on Jan 06, 2025, when has been sold 10,000 shares (Common Shares) at a price of $6.08 per share, resulting in proceeds of $60,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 83.9K
26.24% 3M change
70.83% 12M change
Total Value Held $545,109

Rosty Raykov Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2025
SELL
Open market or private sale
$60,800 $6.08 p/Share
10,000 Reduced 10.65%
83,863 Common Shares
Dec 31 2024
BUY
Grant, award, or other acquisition
-
2,431 Added 2.52%
93,863 Common Shares
Dec 20 2024
BUY
Exercise of conversion of derivative security
$67,250 $2.69 p/Share
25,000 Added 21.47%
91,432 Common Shares
Dec 05 2024
SELL
Open market or private sale
$4,807 $6.04 p/Share
796 Reduced 1.18%
66,432 Common Shares
Dec 03 2024
SELL
Open market or private sale
$10,022 $6.13 p/Share
1,635 Reduced 2.37%
67,228 Common Shares
Dec 02 2024
BUY
Grant, award, or other acquisition
-
2,431 Added 3.41%
68,863 Common Shares
Nov 04 2024
SELL
Open market or private sale
$10,477 $4.31 p/Share
2,431 Reduced 3.53%
66,432 Common Shares
Oct 31 2024
BUY
Grant, award, or other acquisition
-
2,431 Added 3.41%
68,863 Common Shares
Oct 01 2024
SELL
Open market or private sale
$12,009 $4.94 p/Share
2,431 Reduced 3.53%
66,432 Common Shares
Sep 30 2024
BUY
Grant, award, or other acquisition
-
2,431 Added 3.41%
68,863 Common Shares
Sep 04 2024
SELL
Open market or private sale
$13,419 $5.52 p/Share
2,431 Reduced 3.53%
66,432 Common Shares
Aug 31 2024
BUY
Grant, award, or other acquisition
-
2,431 Added 3.41%
68,863 Common Shares
Aug 23 2024
SELL
Bona fide gift
-
95,038 Reduced 50.69%
92,433 Common Shares
Aug 01 2024
SELL
Open market or private sale
$15,193 $6.25 p/Share
2,431 Reduced 1.28%
187,471 Common Shares
Jul 31 2024
BUY
Grant, award, or other acquisition
-
2,431 Added 1.26%
189,902 Common Shares
Jul 02 2024
SELL
Open market or private sale
$14,902 $6.13 p/Share
2,431 Reduced 1.28%
187,471 Common Shares
Jul 01 2024
BUY
Grant, award, or other acquisition
-
2,431 Added 1.26%
189,902 Common Shares
Jun 03 2024
SELL
Open market or private sale
$16,433 $6.76 p/Share
2,431 Reduced 1.28%
187,471 Common Shares
May 31 2024
BUY
Grant, award, or other acquisition
-
2,431 Added 1.26%
189,902 Common Shares
May 01 2024
SELL
Open market or private sale
$22,146 $9.11 p/Share
2,431 Reduced 1.28%
187,471 Common Shares
Apr 30 2024
BUY
Grant, award, or other acquisition
-
2,431 Added 1.26%
189,902 Common Shares
Apr 05 2024
SELL
Open market or private sale
$476,225 $10.75 p/Share
44,300 Reduced 19.11%
187,471 Common Shares
Apr 04 2024
SELL
Open market or private sale
$482,241 $10.89 p/Share
44,283 Reduced 16.04%
231,771 Common Shares
Apr 03 2024
SELL
Open market or private sale
$437,495 $10.78 p/Share
40,584 Reduced 12.82%
276,054 Common Shares
Apr 01 2024
BUY
Open market or private purchase
-
29,167 Added 8.43%
316,638 Common Shares
RR

Rosty Raykov

Durham, NC

Track Institutional and Insider Activities on FENC

Follow FENNEC PHARMACEUTICALS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FENC shares.

Notify only if

Insider Trading

Get notified when an Fennec Pharmaceuticals Inc. insider buys or sells FENC shares.

Notify only if

News

Receive news related to FENNEC PHARMACEUTICALS INC.

Track Activities on FENC